vs
Side-by-side financial comparison of FULTON FINANCIAL CORP (FULT) and Natera, Inc. (NTRA). Click either name above to swap in a different company.
Natera, Inc. is the larger business by last-quarter revenue ($665.5M vs $336.2M, roughly 2.0× FULTON FINANCIAL CORP). FULTON FINANCIAL CORP runs the higher net margin — 28.2% vs 7.1%, a 21.1% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 4.2%). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 0.2%).
Fulton Financial Corporation is an American regional financial services holding company, headquartered in Lancaster, Pennsylvania.
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...
FULT vs NTRA — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $336.2M | $665.5M |
| Net Profit | $94.8M | $47.3M |
| Gross Margin | — | — |
| Operating Margin | — | -3.4% |
| Net Margin | 28.2% | 7.1% |
| Revenue YoY | 4.2% | 39.8% |
| Net Profit YoY | 1.9% | 187.9% |
| EPS (diluted) | $0.55 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $336.2M | — | ||
| Q4 25 | $336.0M | $665.5M | ||
| Q3 25 | $334.6M | $592.2M | ||
| Q2 25 | $324.1M | $546.6M | ||
| Q1 25 | $318.4M | $501.8M | ||
| Q4 24 | $319.6M | $476.1M | ||
| Q3 24 | $317.7M | $439.8M | ||
| Q2 24 | $334.7M | $413.4M |
| Q1 26 | $94.8M | — | ||
| Q4 25 | $99.0M | $47.3M | ||
| Q3 25 | $100.5M | $-87.5M | ||
| Q2 25 | $99.2M | $-100.9M | ||
| Q1 25 | $93.0M | $-66.9M | ||
| Q4 24 | $68.6M | $-53.8M | ||
| Q3 24 | $63.2M | $-31.6M | ||
| Q2 24 | $95.0M | $-37.5M |
| Q1 26 | — | — | ||
| Q4 25 | 35.7% | -3.4% | ||
| Q3 25 | 38.2% | -16.5% | ||
| Q2 25 | 37.8% | -20.2% | ||
| Q1 25 | 36.1% | -15.8% | ||
| Q4 24 | 27.0% | -13.6% | ||
| Q3 24 | 25.1% | -8.9% | ||
| Q2 24 | 30.8% | -10.6% |
| Q1 26 | 28.2% | — | ||
| Q4 25 | 29.5% | 7.1% | ||
| Q3 25 | 30.0% | -14.8% | ||
| Q2 25 | 30.6% | -18.5% | ||
| Q1 25 | 29.2% | -13.3% | ||
| Q4 24 | 21.5% | -11.3% | ||
| Q3 24 | 19.9% | -7.2% | ||
| Q2 24 | 28.4% | -9.1% |
| Q1 26 | $0.55 | — | ||
| Q4 25 | $0.53 | $0.36 | ||
| Q3 25 | $0.53 | $-0.64 | ||
| Q2 25 | $0.53 | $-0.74 | ||
| Q1 25 | $0.49 | $-0.50 | ||
| Q4 24 | $0.36 | $-0.41 | ||
| Q3 24 | $0.33 | $-0.26 | ||
| Q2 24 | $0.52 | $-0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.5B | $1.7B |
| Total Assets | $32.2B | $2.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $1.0M | ||
| Q2 25 | — | $16.0M | ||
| Q1 25 | — | $17.8M | ||
| Q4 24 | — | $22.7M | ||
| Q3 24 | — | $29.5M | ||
| Q2 24 | — | $90.3M |
| Q1 26 | $3.5B | — | ||
| Q4 25 | $3.5B | $1.7B | ||
| Q3 25 | $3.4B | $1.3B | ||
| Q2 25 | $3.3B | $1.2B | ||
| Q1 25 | $3.3B | $1.2B | ||
| Q4 24 | $3.2B | $1.2B | ||
| Q3 24 | $3.2B | $878.5M | ||
| Q2 24 | $3.1B | $836.5M |
| Q1 26 | $32.2B | — | ||
| Q4 25 | $32.1B | $2.4B | ||
| Q3 25 | $32.0B | $1.8B | ||
| Q2 25 | $32.0B | $1.8B | ||
| Q1 25 | $32.1B | $1.7B | ||
| Q4 24 | $32.1B | $1.7B | ||
| Q3 24 | $32.2B | $1.6B | ||
| Q2 24 | $31.8B | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $73.9M |
| Free Cash FlowOCF − Capex | — | $37.8M |
| FCF MarginFCF / Revenue | — | 5.7% |
| Capex IntensityCapex / Revenue | — | 5.4% |
| Cash ConversionOCF / Net Profit | — | 1.56× |
| TTM Free Cash FlowTrailing 4 quarters | — | $109.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $304.5M | $73.9M | ||
| Q3 25 | $116.1M | $59.4M | ||
| Q2 25 | $91.7M | $37.6M | ||
| Q1 25 | $703.0K | $44.5M | ||
| Q4 24 | $416.6M | $52.9M | ||
| Q3 24 | $-22.0M | $51.8M | ||
| Q2 24 | $157.8M | $4.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $37.8M | ||
| Q3 25 | — | $37.0M | ||
| Q2 25 | — | $11.7M | ||
| Q1 25 | — | $22.6M | ||
| Q4 24 | — | $34.8M | ||
| Q3 24 | — | $35.5M | ||
| Q2 24 | — | $-7.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.7% | ||
| Q3 25 | — | 6.2% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | — | 8.1% | ||
| Q2 24 | — | -1.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.4% | ||
| Q3 25 | — | 3.8% | ||
| Q2 25 | — | 4.7% | ||
| Q1 25 | — | 4.3% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | — | 2.8% |
| Q1 26 | — | — | ||
| Q4 25 | 3.08× | 1.56× | ||
| Q3 25 | 1.16× | — | ||
| Q2 25 | 0.92× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 6.07× | — | ||
| Q3 24 | -0.35× | — | ||
| Q2 24 | 1.66× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
